Log in
Systemic acidifier

Ammonium chloride

Ammonium chloride is a systemic acidifier that lowers blood pH and urine pH by releasing hydrogen ions and chloride. It is primarily used to treat metabolic alkalosis and to acidify urine in patients with certain infections. The key exam fact: ammonium chloride generates H⁺ ions via hepatic metabolism, making it a direct acidifying agent.

Practice questionsHigh-yield facts
Drug classSystemic acidifier, electrolyte supplement
MechanismHepatic metabolism produces H⁺; acidifies blood and urine
Main usesMetabolic alkalosis, urinary acidification, diuretic therapy
Key adverse effectAcidosis, hyperchloremia, CNS toxicity with overdose
5 min readFor medical studentsUpdated 2026-10-14

Mechanism of action

Ammonium chloride acts as a systemic acidifier through hepatic metabolism. The ammonium ion (NH₄⁺) undergoes transamination in the liver, producing urea and releasing a hydrogen ion (H⁺). This increases the hydrogen ion concentration, lowering blood pH and creating a metabolic acidosis. Simultaneously, the chloride ion is retained, contributing to hyperchloremia. The net effect is a reduction in serum bicarbonate concentration and acidification of the urine, which is therapeutically useful in specific clinical contexts.

High-yield for exams
  • Ammonium chloride is a systemic acidifier metabolized by the liver to produce H⁺ ions and lower blood pH.
  • Primary use: treatment of metabolic alkalosis (especially chloride-responsive) when standard therapy fails.
  • Secondary use: urinary acidification to treat alkaline-urine UTIs caused by urease-producing bacteria (Proteus, Klebsiella).
  • Contraindicated in hepatic cirrhosis and urea cycle disorders due to risk of hyperammonemia and encephalopathy.
  • Key adverse effects: hyperchloremic acidosis, hyperammonemia, hyperkalemia (from extracellular K⁺ shift), and CNS toxicity (confusion, lethargy, coma).
  • Monitor hepatic function, acid–base status, and serum potassium during therapy; rarely used in modern practice but still tested.
  • Ineffective in chloride-resistant alkalosis (urine Cl⁻ >10 mEq/L); check urine chloride before prescribing.
  • Classic exam association: urinary acidification and inhibition of urease-producing UTI pathogens.

Indications

Primary indications:

  • Metabolic alkalosis: Treatment of alkalemia (typically pH >7.50) when standard measures (fluid resuscitation, electrolyte correction) are insufficient. Most effective in chloride-responsive alkalosis.
  • Urinary acidification: Correction of alkaline urine in patients with alkaline urine-dependent infections (e.g., Proteus and Klebsiella urinary tract infections that produce urease and alkaline urine).
  • Diuretic-induced alkalosis: Management of hypokalemic metabolic alkalosis from loop or thiazide diuretics.

Historical/limited use:

  • Adjunctive therapy in ammonia intoxication (rare).
  • Preoperative urine acidification in specific urological procedures (uncommon in modern practice).

Pharmacokinetics

Absorption and distribution: Ammonium chloride is rapidly absorbed when given orally or parenterally. It is widely distributed throughout total body water.

Metabolism: The ammonium ion is metabolized almost exclusively by the liver via the urea cycle (transamination). This process is relatively efficient and concentrates in hepatocytes. Hepatic impairment significantly prolongs duration of action.

Elimination: H⁺ and Cl⁻ ions are renally excreted. The rate of excretion depends on renal function and acid–base status. In metabolic acidosis or renal dysfunction, clearance is prolonged.

Onset and duration: Oral formulations exhibit slower onset (2–6 hours) than intravenous administration (minutes). Effects typically persist 4–8 hours but may be prolonged in renal or hepatic disease.

Adverse effects

Common:

  • Hyperchloremic acidosis: Excessive acidification leading to serum pH <7.35, elevated chloride (>110 mEq/L), and reduced bicarbonate. Can precipitate respiratory compensation or worsen existing acidosis.
  • Hyperchloremia: Elevated serum chloride often asymptomatic but contributes to acidosis.
  • Hyperkalemia: Acidosis shifts potassium extracellularly, potentially causing elevated serum potassium levels, particularly in patients with renal impairment or on potassium-sparing agents.

CNS effects (with overdose or rapid administration):

  • Headache, confusion, lethargy, somnolence.
  • Twitching, tremor, coma in severe cases.
  • Due to increased ammonia and acidosis affecting neuronal function.

Metabolic complications:

  • Ammonia intoxication: Particularly in patients with hepatic cirrhosis or urea cycle disorders; risk is greatest in these populations.
  • Hyperammonemia: Ammonium accumulation when hepatic clearance is impaired.
  • Increased uric acid: May precipitate acute gout in predisposed patients.

Other:

  • Local irritation or phlebitis with intravenous administration.
  • GI upset, nausea with oral formulations.
  • Hypokalemia (less common but may occur with concurrent diuretic use).

Contraindications and warnings

Absolute contraindications:

  • Hepatic cirrhosis or severe hepatic disease: High risk of ammonia intoxication and encephalopathy due to impaired urea cycle function.
  • Urea cycle disorders: Genetic defects in ammonium metabolism (e.g., ornithine transcarbamylase deficiency) contraindicate ammonium salts.
  • Primary hyperammonemia: Pre-existing elevated ammonia levels.
  • Renal failure (severe): Impaired clearance of acidifying ions; risk of severe acidosis.
  • Metabolic acidosis (pre-existing): Ammonium chloride worsens acidemia.

Relative contraindications and cautions:

  • Pulmonary disease: Respiratory acidosis combined with metabolic acidosis from ammonium chloride is dangerous.
  • Cardiac arrhythmias: Acidosis and electrolyte shifts can destabilize cardiac conduction.
  • Hyperkalemia risk: Acidosis-induced extracellular potassium shift can worsen hyperkalemia; monitor potassium closely.
  • Pregnancy: Limited safety data; use only if clearly indicated. May cross placenta and affect fetal acid–base balance.
  • Lactation: Excretion into breast milk is minimal; generally considered compatible.

Black box warning or serious warnings: While not universally labeled as a black box warning in all jurisdictions, ammonium chloride carries a serious risk of ammonia toxicity in cirrhotic patients and those with urea cycle disorders. Hepatic function should be confirmed before use.

Drug interactions

With other acidifying agents:

  • Concurrent use with other systemic acidifiers (e.g., acetazolamide, topiramate) increases risk of severe metabolic acidosis. Avoid or use with careful monitoring.

With potassium-modifying drugs:

  • Loop and thiazide diuretics: May cause hypokalemia; monitor potassium levels and supplement as needed.
  • ACE inhibitors and angiotensin II receptor blockers: Increased risk of hyperkalemia due to acidosis-induced extracellular potassium shift.
  • Potassium-sparing diuretics: Risk of hyperkalemia; avoid concurrent use.

With ammonia-metabolizing drugs:

  • Valproic acid: May increase ammonia levels; caution in concurrent use.
  • Drugs inducing hepatic enzymes: May accelerate ammonium chloride metabolism (minor).

With other agents:

  • Sympathomimetics and stimulants: Acidosis can enhance sympathomimetic effects; monitor blood pressure and heart rate.
  • Anticonvulsants: Acidosis may lower seizure threshold in some patients; use with caution in epilepsy.

Clinical pearls

  • Chloride-responsive vs. chloride-resistant alkalosis: Ammonium chloride is most effective in chloride-responsive alkalosis (urine chloride <10 mEq/L, usually from vomiting or diuretics). Ineffective in chloride-resistant alkalosis (urine chloride >10 mEq/L).
  • Hepatic metabolism is key: Always check hepatic function before prescribing. Cirrhotic patients are at extreme risk for ammonia toxicity.
  • Monitor acid–base status carefully: Serial blood gas and electrolytes (especially K⁺, Cl⁻, NH₃) should be obtained during therapy to avoid overcorrection.
  • Rarely used in modern practice: Ammonium chloride is infrequently used today due to availability of safer alternatives (e.g., normal saline, hydrochloric acid infusion in ICU settings). However, it remains relevant for USMLE exams and for specific indications like urinary acidification in UTI management.
  • Urine pH reversal in UTI: In alkaline-urine UTIs caused by urease-producing organisms, acidifying urine with ammonium chloride can inhibit bacterial growth and improve antibiotic efficacy; this is a classic exam association.
  • Dosing follows product label: Exact dosing depends on the degree of alkalosis, renal function, and hepatic function and should be individualized according to laboratory results and clinical response.
Mnemonic

ACI-D: Ammonia (hepatic metabolism), Chloride (hyperchloremia), Increases H⁺ (acidification), Danger in cirrhosis.

Practice questions

1. A 58-year-old man with cirrhosis and ascites presents with metabolic alkalosis (pH 7.52, HCO₃⁻ 42 mEq/L) after prolonged vomiting and diuretic use. His urine chloride is 8 mEq/L. A medical student recommends ammonium chloride therapy. Which of the following is the most important reason to avoid this drug?

Answer: B. In hepatic cirrhosis, the urea cycle is impaired, so ammonium ions accumulate instead of being converted to urea. This leads to hyperammonemia and hepatic encephalopathy—a life-threatening complication. Option 0 is incorrect (acidosis typically raises serum K⁺, causing hyperkalemia, not severe hyperkalemia as the primary concern). Option 2 is wrong (low urine Cl⁻ = 8 mEq/L indicates chloride-responsive alkalosis, for which ammonium chloride is theoretically appropriate, but contraindicated by cirrhosis). Options 3 and 4 are factually incorrect.

2. A 35-year-old woman with recurrent UTIs due to Proteus mirabilis (urease-positive) and persistently alkaline urine (pH 7.8) is started on ammonium chloride to acidify her urine. Which mechanism best explains the therapeutic benefit in this clinical scenario?

Answer: B. Urease-producing bacteria (Proteus, Klebsiella) generate ammonia and alkaline urine. Ammonium chloride lowers urine pH, creating an acidic environment that inhibits urease activity and bacterial growth. Acidic urine also enhances the efficacy of pH-sensitive antibiotics like methenamine and nitrofurantoin. Option 0 is incorrect (ammonium chloride does not directly inhibit cell wall synthesis). Option 2 is not the mechanism. Options 3 and 4 are incorrect or indirect mechanisms.

3. A 52-year-old man on loop diuretics for heart failure develops metabolic alkalosis (HCO₃⁻ 40 mEq/L, urine Cl⁻ 6 mEq/L, K⁺ 2.8 mEq/L). Before starting ammonium chloride, which laboratory value is most important to verify to avoid a life-threatening complication?

Answer: A. Before administering ammonium chloride, hepatic function must be assessed because the drug is metabolized by the liver. Patients with cirrhosis or hepatic failure are at extreme risk for hyperammonemia and encephalopathy. Verifying normal hepatic synthetic function (PT/INR, albumin) and checking baseline ammonia levels prevents this life-threatening complication. Option 4 (renal function) is important but secondary; even with mild renal impairment, ammonium chloride can be used cautiously. Options 1, 2, and 3 are not the primary safety concern.

Frequently asked questions

How does ammonium chloride work?

Ammonium chloride is metabolized by the liver, producing hydrogen ions (H⁺) and chloride. This lowers serum pH and urine pH. The mechanism is direct acidification via hepatic transamination of ammonium ions, generating H⁺ that titrates serum bicarbonate and increases urine acidity.

What are the main uses of ammonium chloride?

Ammonium chloride is used to treat metabolic alkalosis (especially chloride-responsive) and to acidify urine in patients with alkaline-urine UTIs caused by urease-producing bacteria. It is also used adjunctively in diuretic-induced hypokalemic alkalosis, though safer alternatives are often preferred in modern practice.

What are the serious adverse effects of ammonium chloride?

Serious adverse effects include hyperchloremic acidosis, hyperammonemia (particularly in cirrhotic patients), hyperkalemia (from acidosis-induced extracellular potassium shift), and CNS toxicity (confusion, lethargy, coma). Ammonia intoxication is life-threatening in patients with hepatic cirrhosis or urea cycle disorders and is the primary reason for contraindication in these populations.

Why is ammonium chloride contraindicated in hepatic cirrhosis?

Hepatic cirrhosis impairs the urea cycle, preventing efficient metabolism of ammonium ions. This leads to accumulation of ammonia (hyperammonemia) and increased risk of hepatic encephalopathy, characterized by confusion, tremor, and potentially coma. Ammonium chloride directly worsens this by increasing substrate for ammonia production.

How does ammonium chloride help treat urinary tract infections?

Ammonium chloride acidifies the urine, reducing urine pH. This is therapeutically useful in infections caused by urease-producing bacteria (Proteus, Klebsiella) that generate ammonia and alkaline urine. An acidic urine environment inhibits bacterial growth and enhances the efficacy of certain antibiotics, particularly methenamine and nitrofurantoin.

Conditions it is used for

Metabolic alkalosisChloride-responsive alkalosisDiuretic-induced alkalosisAlkaline urine UTIProteus urinary tract infectionKlebsiella urinary tract infectionUrinary acidificationHypokalemic metabolic alkalosis
Hydrochloric acid (HCl)AcetazolamideTopiramateThiazide diureticsLoop diureticsSodium bicarbonatePotassium chlorideTromethamine (THAM)

Sources and further reading

DailyMed (FDA labels)StatPearls (NCBI Bookshelf)MedlinePlusWHO ATC/DDD index: B05XA04WHO ATC/DDD index: G04BA01

Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.